Assessment of the infant at risk.
D001034:Apgar Score; D001519:Behavior; D001769:Blood; D001921:Brain / Q000196:embryology; D001923:Brain Chemistry; D002490:Central Nervous System / Q000503:physiopathology; D002657:Child Development; D004247:DNA / Q000032:analysis; D005314:Embryonic and Fetal Development; D005260:Female; D005333:Fetus / Q000187:drug effects; D005865:Gestational Age; D003932:Heroin / Q000009:adverse effects; D006728:Hormones / Q000378:metabolism; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis*; D007235:Infant, Premature, Diseases / Q000175:diagnosis; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D009034:Mother-Child Relations; D009460:Neurologic Examination; D009461:Neurologic Manifestations; D010929:Placentation; D011247:Pregnancy; D014149:Tranquilizing Agents / Q000009:adverse effects; D014470:Umbilical Cord
D006728:Hormones; D014149:Tranquilizing Agents; D003932:Heroin; D008238:Lysergic Acid Diethylamide; D004247:DNA